Metraipolis › archive › dc_5bb21fa5422c
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Risk of Gynecologic Cancer: A Nationwide Cohort Study — Europe PMC PMID:41899499
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41899499
- DOI
- 10.3390/cancers18060894
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T23:29:37.143Z
- SHA-256 of the archived text
afcd5f5c6934be2959b815674adf82f568318c4e1ff6d547cabcbc36e0fc0a1a- Stable URL of this page
https://metraipolis.com/documento/dc_5bb21fa5422c
How to cite
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Risk of Gynecologic Cancer: A Nationwide Cohort Study — Europe PMC PMID:41899499 — Europe PMC (en), https://europepmc.org/article/MED/41899499 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5bb21fa5422c (Metraipolis archive dc_5bb21fa5422c, sha256 afcd5f5c6934be2959b815674adf82f568318c4e1ff6d547cabcbc36e0fc0a1a)
BibTeX
@misc{dc5bb21fa5422c,
title = {Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Risk of Gynecologic Cancer: A Nationwide Cohort Study — Europe PMC PMID:41899499},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41899499},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5bb21fa5422c; sha256 afcd5f5c6934be2959b815674adf82f568318c4e1ff6d547cabcbc36e0fc0a1a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41899499. Agents can read the archived copy with the MCP tool read_document.